New Key Statistics Module, Z-Score and F-Score
SZSE:002793 Key Ratios
Market Cap ¥ M | 5,176.92 |
Enterprise Value ¥ M | 6,214.18 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 2.45 |
Price/Sales | 2.08 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) ¥ M | 2,418.00 |
EPS (TTM) ¥ | -0.65 |
Beneish M-Score | -3.58 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -10.55 |
EV-to-EBITDA | -10.55 |
PEG | -- |
Shares Outstanding M | 1,087.59 |
Net Margin (%) | -28.82 |
Operating Margin % | -16.53 |
Pre-tax Margin (%) | -26.89 |
Quick Ratio | 0.63 |
Current Ratio | 0.85 |
ROA % (ttm) | -13.28 |
ROE % (ttm) | -28.70 |
ROIC % (ttm) | -10.68 |
Dividend Yield % | -- |
Altman Z-Score | 1.28 |
SZSE:002793 Number of Guru Trades
SZSE:002793 Volume of Guru Trades
Gurus Latest Trades with SZSE:002793
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:002793 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Luoxin Pharmaceuticals Group Stock Co Ltd Insider Transactions
No Available Data